Article
Bone mineral density utilization in patients with newly diagnosed multiple myeloma.
Hematological oncology - 1 Dec 2017
Muchtar Eli, Dagan Adi, Robenshtok Eyal, Shochat Tzippy, Oniashvili Nino, Amitai Irina, Raanani Pia, Magen Hila
Abstract excerpt
Bone disease is a major cause for morbidity in multiple myeloma (MM), with the main focus concerning the manifestation as osteolytic lesions. Bone mineral loss is another reflection of myeloma bone involvement. Recently, osteoporosis has been omitted as a defining criterion for symptomatic disease in MM. We conducted a retrospective study to evaluate the use of bone mineral density (BMD) exams by dual-energy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.